Pancreatic Cancer Action Network
2 clinical trials · Sponsor
◉ Watch Pancreatic Cancer Action Network
| Record | Firm | Date |
|---|---|---|
| Early Detection Initiative for Pancreatic Cancer (NCT04662879) | Pancreatic Cancer Action Network | 2021-10-14 |
| A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients (NCT04581343) | Pancreatic Cancer Action Network | 2020-11-02 |
Track Pancreatic Cancer Action Network automatically
Every clearance here is in the API, with alerts when new ones post.